window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

PCR testing

  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Seegene data finds STI pathogens in 82% of HPV-positive test results

    Seegene analysis of about 60,000 test results found STI pathogens [...]

    July 28, 2026
  • Clinical & Regulatory,Digital & Data,Genomics and sequencing,Research & Development

    Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections

    Seegene has launched the Global Million Clinical Study (GMCS), an [...]

    July 16, 2026
  • Digital & Data,Medical devices,Research & Development

    Seegene launches global million-patient study of syndromic PCR testing

    Seegene has launched a global clinical study involving one million [...]

    July 9, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Cytespace Africa Labs expands molecular testing capacity to support clinical trials across sub-Saharan Africa

    Cytespace Africa Laboratories has expanded its molecular testing capacity to [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • APAC ablation catheter market set to grow 14% as pulsed field ablation gains ground
    Categories: Medical devices
  • Andelyn and Queen’s University partner on AAV9 gene therapy for GM2 gangliosidoses
    Categories: Advanced Therapies, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
  • Piramal Pharma takes controlling stake in Yapan Bio
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top